Stanford University
Showing 12,321-12,340 of 13,041 Results
-
John Witte
Professor of Epidemiology and Population Health, of Biomedical Data Science and of Genetics
Current Research and Scholarly InterestsThe Witte Lab is a computational and statistical genetics group focused on deciphering the genetic and molecular mechanisms underlying cancer and other complex traits. We undertake integrative analyses across large multi-ancestry cohorts and biobanks, developing and applying methods at the interface of epidemiology, statistical genetics, and machine learning.
-
Ronald Witteles
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests1) Amyloidosis -- Optimizing diagnosis/therapy and discovering new treatments
2) CardioOncology -- Understanding, treating, and preventing cancer therapy-induced cardiotoxicity
3) Sarcoidosis -- Exploring novel diagnostic modalities and determining optimal treatment, with a focus on cardiac sarcoidosis -
Temesgen 'Tem' Woldeyesus
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Tem (Temesgen) is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population Health. He obtained his medical degree at UCSF and continued his residency training at UCSF in Family and Community Medicine. He was selected as Chief Resident, where he further developed as a clinical educator and administrator, prior to joining the faculty group at Stanford. His academic interests include alternative models of care, clinical informatics, and digital health equity.
Dr. Tem Woldeyesus practices full-spectrum family medicine, which includes care for the entire age spectrum. He is driven to provide evidence-based, high quality, culturally competent care.
He is a native of the Bay Area. Outside of work, he enjoys spending time with his fiancée, playing (and watching) basketball, and exploring national parks. -
Albert J. Wong, M.D.
Professor of Neurosurgery
Current Research and Scholarly InterestsOur goal is to define targets for cancer therapeutics by identifying alterations in signal transduction proteins. We first identified a naturally occurring mutant EGF receptor (EGFRvIII) and then delineated its unique signal transduction pathway. This work led to the identification of Gab1 followed by the discovery that JNK is constitutively active in tumors. We intiated using altered proteins as the target for vaccination, where an EGFRvIII based vaccine appears to be highly effective.
-
Becky Wong
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Becky Wong is board certified in adult and pediatric anesthesiology and practices anesthesiology at Stanford University Hospitals and Clinics and The Lucile Packard Children’s Hospital in Stanford, California. She received her medical school degree at The University of California at San Diego and her anesthesia residency and pediatric anesthesia fellowship training at Stanford. She provides anesthesia care for a wide range of ages with a focus on neuroanesthesia. She co-chairs the Neuroanesthesia Special Interest Group in the Society for Pediatric Anesthesia. As an Associate Director for Quality Improvement in the Stanford Anesthesia Department, she has a deep interest in improving patient care.
